Components of Pneumococcal Vaccine	Excipients Table Allergens Table Components Table
Indication Immunity in infants and children against S. pneumoniae Proprietary Name Prevnar Prevnar-13 Pneumovax 23 Manufacturers Wyeth Wyeth Merck Viability Inactivated   Inactivated Microorganism Streptococcus pneumoniae 7-valent serotype Streptococcus pneumoniae 13-valent serotype Streptococcus pneumoniae 23-valent serotype Indicated Ages   6 wks - 17 yrs and 50+ yrs   Pediatric Dose 0.5 mL 6 wk - 17 yr : 0.5 mL 0.5 mL Adult Dose   50 and older: 0.5 mL   Route Intramuscular Intramuscular Intramuscular or Subcutaneous Dose form Suspension   Solution Appearance Homogeneous, white suspension Homogeneous, white suspension Clear, colorless solution Concentration (per 0.5 mL) Serotypes 4, 9V, 14, 18C, 19F, and 23F, 2 mcg each Serotypes 6B, 4 mcg Serotypes s 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 23F, 2.2 mcg each Serotypes 6B, 4.4 mcg 23 polysaccharides, 25 mcg for each (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, 33F) Excipients None   None Adjuvants Diphtheria CRM197, 20 mcg Aluminum phosphate, 0.125 mg CRM197 carrier protein, 34 mcg Polysorbate 80, 100 mcg Succinate buffer, 295 mcg  Aluminum phosphate, 125 mcg None Allergens Dry natural rubber   None Preservatives None   Phenol, 0.25% Media Soy peptone broth   Bovine proteins and other macromolecular components Packaging Vial, 1 dose (5 per package)   Vials, 5-dose, 10 5-dose vials, 10 single-dose vial Routine storage 2 to 8° C (35-46° F) Do not freeze   2 to 8° C (35-46° F) Do not freeze Package Insert last updated   01/2013   updated Feb 2013
This page was last updated on February 15, 2013 © 2004 Institute for Vaccine Safety